A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2017
Price : $35 *
At a glance
- Drugs Lemborexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 07 Dec 2017 According to an Eisai media release, results from this trial have been published in the Journal of Clinical Sleep Medicine.
- 20 May 2017 Results presented at the 2017 Annual Scientific Meeting of the American Geriatrics Society
- 15 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.